Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

GILD is going to be the next Amazon

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
doc063 Member Profile
 
Followed By 30
Posts 4,009
Boards Moderated 2
Alias Born 03/04/17
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/25/2020 5:05:20 PM
European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate ... Business Wire - 9/25/2020 1:00:00 PM
Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthritis Business Wire - 9/25/2020 2:00:00 AM
Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes Business Wire - 9/23/2020 10:33:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/23/2020 9:10:48 AM
Gilead's Magrolimab Gets FDA Breakthrough Therapy Designation in Myelodysplastic Syndrome Dow Jones News - 9/15/2020 8:54:00 AM
Gilead’s Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, Receives FDA Breakthrough Therapy Designation for Tr... Business Wire - 9/15/2020 8:00:00 AM
Hospitalized Covid-19 Patients Recovered Faster With Arthritis Drug Dow Jones News - 9/14/2020 11:26:00 AM
Immunomedics Shares More Than Double After Gilead Deal Dow Jones News - 9/14/2020 8:26:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 8:02:48 AM
Gilead Acquires Cancer-Drug Maker -- WSJ Dow Jones News - 9/14/2020 3:02:00 AM
Gilead Reaches Deal to Buy Immunomedics for $21 Billion -- 5th Update Dow Jones News - 9/13/2020 9:01:00 PM
Gilead Reaches Deal to Buy Immunomedics for $21 Billion--4th Update Dow Jones News - 9/13/2020 4:29:00 PM
Gilead Sciences to Acquire Immunomedics Business Wire - 9/13/2020 3:00:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--3rd Update Dow Jones News - 9/12/2020 4:01:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--2nd Update Dow Jones News - 9/12/2020 3:50:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--Update Dow Jones News - 9/12/2020 3:39:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion Dow Jones News - 9/12/2020 3:22:00 PM
Kite Submits Supplemental Biologics License Application to U.S. Food & Drug Administration for Yescarta® in Relapsed or Refr... Business Wire - 9/4/2020 8:30:00 AM
Gilead's Kite Forms AML Collaboration With HiFiBiO Therapeutics Dow Jones News - 9/3/2020 8:56:00 AM
Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia Business Wire - 9/3/2020 8:00:00 AM
Jounce Therapeutics Shares Up 54% After License Agreement With Gilead Dow Jones News - 9/1/2020 10:21:00 AM
Gilead, Jounce In License Agreement for Immunotherapy Program Dow Jones News - 9/1/2020 9:19:00 AM
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program GlobeNewswire Inc. - 9/1/2020 8:30:10 AM
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program Business Wire - 9/1/2020 8:30:00 AM
doc063   Thursday, 04/30/20 02:40:55 PM
Re: None
Post # of 4376 
GILD is going to be the next Amazon or Tesla. Take a very good position and ready for the Big Bang...It's coming very soon!


















______________________________________________________________________


My comments are based on personal opinions. Please do your own DD before you invest.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences